Athens, Feb 2011.
Vioryl SA, a chemical and biotechnology company with leading position in the Hellenic and global markets is investing in Fasmatech in a cash-for-shares deal. For over half a century Vioryl heads its way to progress and success holding tight to its principles of expanding knowledge and providing its customers with products of the highest quality, tailor made solutions and innovative ideas. Pursuing a leading position in the global fine chemicals and natural products market Vioryl made a strategic investment in Fasmatech to strengthen its analytical chemistry capabilities with unique leading edge technologies.
In finding a strong partner with real-world analytical needs, Fasmatech consolidates its links with leading edge applications of mass spectrometry and ion mobility.
Details of the financial terms of the deal have not been disclosed.
